Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
NCT01604733 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2012-05-24
Summary
Study objective is to evaluate the level of control of hypercholesterolemia in Egypt in patients taking lipid lowering agents for at least 3 months ( with no drug change or dose amendment for a minimum of 6 weeks).
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Mohie E Sherif, MD · Ethical committee, Faculty of medicine, Alexandria University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
More Related Trials
-
Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia
NCT01027624 ·Status: COMPLETED
-
Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study
NCT05080140 ·Status: UNKNOWN
-
Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia
NCT01166633 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Ezetimibe on Oxidized Low-density Lipoprotein (LDL) Cholesterol
NCT01008345 ·Status: COMPLETED ·Phase: PHASE4
-
Pan-European Survey on the Under Treatment of Hypercholesterolemia
NCT00542867 ·Status: COMPLETED
-
A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia
NCT04964557 ·Status: COMPLETED ·Phase: PHASE2
-
Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
NCT00409773 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Undertreatment of Patients With Dyslipidemia in Bulgaria
NCT01075594 ·Status: COMPLETED
-
Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women
NCT00163163 ·Status: COMPLETED ·Phase: PHASE3
-
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)
NCT00092833 ·Status: TERMINATED ·Phase: PHASE3
-
EZETROL® Re-examination Study (MK0653-175)(COMPLETED)
NCT01070953 ·Status: COMPLETED
-
Tracking of Lipid Lowering Therapy in Jordan
NCT05629767 ·Status: TERMINATED
-
Drug-Drug Interaction Study Between Colchicine and Atorvastatin
NCT00960323 ·Status: COMPLETED ·Phase: PHASE1
-
Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian Population
NCT03799185 ·Status: COMPLETED
-
Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases
NCT03433196 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia
NCT06173570 ·Status: COMPLETED ·Phase: PHASE2
-
An ADME Study of [14C]AZD0780 in Healthy Male Subjects
NCT05817461 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia
NCT02942602 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
NCT01370603 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)
NCT00652327 ·Status: COMPLETED ·Phase: PHASE4
-
An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)
NCT00092638 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe-Rosuvastatin Evaluation Study
NCT03947866 ·Status: UNKNOWN
-
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
NCT00535405 ·Status: COMPLETED ·Phase: PHASE3
-
Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal
NCT00781560 ·Status: COMPLETED